Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11952397 Crystalline forms of a neuroactive steroid

Patent 11952397 was granted and assigned to SAGE Therapeutics on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119523970

Patent Inventor Names

Tianrui Li0

Shanming Kuang0

Date of Patent

April 9, 2024

Patent Application Number

183639420

Date Filed

August 2, 2023

Patent Citations

‌

US Patent 7729773 Neural stimulation and optical monitoring systems and methods

‌

US Patent 11236121 Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid

Patent Primary Examiner

‌

Samantha L Shterengarts

CPC Code

‌

C07J 43/003

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11952397 Crystalline forms of a neuroactive steroid

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API